627 related articles for article (PubMed ID: 35802474)
1. N6-methyladenosine (m6A) modification in gynecological malignancies.
Zhang C; Liu N
J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.
Tan F; Zhao M; Xiong F; Wang Y; Zhang S; Gong Z; Li X; He Y; Shi L; Wang F; Xiang B; Zhou M; Li X; Li Y; Li G; Zeng Z; Xiong W; Guo C
J Exp Clin Cancer Res; 2021 Apr; 40(1):146. PubMed ID: 33926508
[TBL] [Abstract][Full Text] [Related]
3. The role of N6-methyladenosine (m6A) in eye diseases.
Gao JF; Zhang L
Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
[TBL] [Abstract][Full Text] [Related]
4. Research progress on N6-methyladenosine in the human placenta.
Zhou W; Xue P; Yang Y; Xia L; Yu B
J Perinat Med; 2022 Oct; 50(8):1115-1123. PubMed ID: 35606944
[TBL] [Abstract][Full Text] [Related]
5. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
7. The role of m6A RNA methylation in cancer.
Sun T; Wu R; Ming L
Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.
Li B; Wang X; Li Z; Lu C; Zhang Q; Chang L; Li W; Cheng T; Xia Q; Zhao P
Insect Mol Biol; 2019 Oct; 28(5):703-715. PubMed ID: 30957943
[TBL] [Abstract][Full Text] [Related]
10. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
11. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
[TBL] [Abstract][Full Text] [Related]
12. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
13. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
15. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
17. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
18. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
Front Surg; 2022; 9():819335. PubMed ID: 35155557
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
[TBL] [Abstract][Full Text] [Related]
20. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
Liu Q
Front Genet; 2021; 12():825109. PubMed ID: 35087575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]